Sign in to continue:

Wednesday, May 6th, 2026

Diversified Healthcare Trust Q1 2026 Financial Results and SEC Filing Highlights





Diversified Healthcare Trust Q1 2026: Key Financials and Shareholder Updates

Diversified Healthcare Trust Reports Q1 2026 Results: Key Financials and Shareholder Information

Overview

Diversified Healthcare Trust (Nasdaq: DHC) has released its unaudited financial results for the first quarter ended March 31, 2026. The report provides a comprehensive snapshot of the company’s financial position, operational performance, and relevant events that may impact shareholder value.

Key Highlights and Financial Metrics

  • Net Loss: The company reported a net loss of \$43.3 million for Q1 2026, a significant deterioration compared to a net loss of \$8.9 million in Q1 2025. The loss per share (basic and diluted) was \$(0.18) compared to \$(0.04) in the prior year period.
  • Total Revenues: Total revenue figures for the quarter are not explicitly detailed in the summary table, but the company’s overall operating performance was negative.
  • Operating Expenses: General and administrative expenses increased to \$14.0 million from \$9.0 million in the comparable period last year. No asset impairment charges were recorded in Q1 2026 (compared to none in Q1 2025).
  • Interest Expense: Interest and other income stood at \$0.2 million for Q1 2026, a decrease from \$2.1 million in Q1 2025. Interest expense, including net amortization of debt discounts, was \$2.3 million.
  • Equity Investments: Equity in net earnings of investees contributed positively with \$0.1 million for Q1 2026, but lower than \$1.5 million in Q1 2025.
  • Comprehensive (Loss) Income: The company reported a comprehensive net loss of \$(43.4) million for the period.
  • Dividends: Common stock dividends declared and paid totaled \$2.42 million in the quarter.

Balance Sheet Key Points (as of March 31, 2026)

  • Total Assets: \$4.27 billion
  • Total Liabilities: Details not broken out in this summary, but include substantial senior unsecured notes and secured debt.
  • Shareholders’ Equity: \$1.62 billion
  • Common Shares Outstanding: 242,108,632 shares on March 31, 2026. As of April 30, 2026, the number of shares outstanding was 241,206,926.
  • Senior Unsecured Notes: \$1.58 billion (net)
  • Secured Debt and Finance Leases: \$454.6 million (net)
  • Additional Paid-in Capital: \$4.62 billion
  • Cumulative Common Dividends: \$(4.08) billion

Operational and Capital Markets Update

  • Share Repurchases: During the quarter, the company repurchased 12,393 shares for a total of \$88,000. This is a marginal reduction in the outstanding float and may have a limited effect on the stock price.
  • Share Grants: The company recorded \$716,000 in share-based compensation expense.
  • Dividend Policy: The company continues to pay dividends, but the payout is substantially lower than historical levels, reflecting the ongoing losses.
  • Filing Status: DHC is a “Large Accelerated Filer” and is current on all required SEC filings.
  • Shell Company Status: DHC is not a shell company.

Potential Price-Sensitive Items for Shareholders

  • Widening Losses: The acceleration in net losses (from \$(8.9) million to \$(43.3) million year-over-year) may be viewed negatively and could pressure the share price.
  • Dividend Sustainability: Given the ongoing losses and lower dividend payouts, there may be concerns about the sustainability of future dividends.
  • Share Buybacks: The company is making only small repurchases, indicating limited ability or willingness to return capital to shareholders at this time.
  • Balance Sheet Strength: While the company’s equity base remains substantial, the accumulation of losses and significant debt load are important considerations for investors.

Summary Table of Key Q1 2026 Metrics

Metric Q1 2026 Q1 2025
Net Loss \$(43.3) million \$(8.9) million
EPS (Basic/Diluted) \$(0.18) \$(0.04)
G&A Expenses \$14.0 million \$9.0 million
Dividends Paid \$2.42 million
Weighted Avg. Shares Outstanding 240.7 million 240.0 million
Shareholders’ Equity \$1.62 billion \$1.67 billion (as of Dec 31, 2025)

Conclusion

Diversified Healthcare Trust’s Q1 2026 results signal ongoing operational and financial challenges, with expanded net losses and increasing administrative costs. The company continues to maintain a large equity base and asset portfolio but faces questions about dividend sustainability and overall profitability. Investors should closely monitor future quarters for signs of operational improvement or further deterioration.


Disclaimer: This article is for informational purposes only. It does not constitute investment advice or an offer to buy or sell any securities. Investors should consult their own advisors and review the full SEC filings before making investment decisions.




View DIVERSIFIED HEALTHCARE TRUST Historical chart here



   Ad

Join Our Investing Seminar

Limited seats available — Reserve your spot today